Loading interface...

Halostar 0.05 % Cream

Manufactured byZydus Cadila
ContainsUlobetasol
Description

Halostar 0.05 % Cream is a potent steroidal medication used to treat redness, itching, swelling, and irritation associated with skin conditions such as eczema, dermatitis, insect bites, and severe allergies.

Side effects

Major & minor side effects for Halostar 0.05 % Cream

  • Blisters under the skin
  • Burning or tingling sensation of skin
  • Itchy and dry skin
  • Easy bruising of skin
  • Unusually warm skin
  • Lightening of skin at the area of application

Uses of Halostar 0.05 % Cream

What is it prescribed for?

  • Dermatitis
  • Eczema
  • Psoriasis
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The amount of time required for this medicine to show its action is not clinically established.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless necessary. The risks and benefits should be discussed with the doctor before using this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless necessary. The risks and benefits should be discussed with the doctor before using this medicine.

Allergy

This medicine is not recommended for use in patients with a known allergy to ulobetasol or any other inactive ingredients present in the formulation.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless necessary. The risks and benefits should be discussed with the doctor before using this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless necessary. The risks and benefits should be discussed with the doctor before using this medicine.
General warnings

Use in children

This medicine is not recommended for use in patients less than 12 years of age since the safety and efficacy of use are not clinically established.

Chronic use

High doses of this medicine should not be used for more than two weeks due to the increased risk of adverse effects. If required, low doses can be used for longterm only under the supervision of your doctor.

Growth retardation

This medicine may cause growth retardation in some children. Therefore, children receiving this medicine should be monitored closely with regard to growth parameters. The dose should be titrated to the minimum effective dose to reduce the chances of such side effects. Replacement with a suitable alternative may be necessary in some cases based on the clinical condition.

External use

This medicine is recommended for external use only. Avoid contact with the eyes, mouth, wounds, or broken skin.

Diabetes Mellitus

This medicine should be used with extreme caution in patients with a known history of diabetes mellitus due to the increased risk of altered blood glucose levels. Close monitoring of blood glucose levels, appropriate dosage adjustments, or replacement with a suitable alternative may be necessary in some cases based on the clinical condition.

Missed Dose

Apply the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not apply a double dose to make up for the missed dose.

Overdose

An overdose of this medicine is not likely to cause severe symptoms. However, the ingestion of this medicine may cause harm and immediate medical intervention may be required.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Insulin

Pioglitazone

Glimepiride

Acarbose

Disease interactions

Infections

This medicine should be used with extreme caution in patients with latent or active infections since this medicine can suppress the immune system and worsen the patient's condition. This risk is especially higher in patients on high doses of this medicine for a prolonged period of time. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition of the patient.

Hyperadrenocorticism

This medicine should be used with caution in patients with a known history of hyperadrenocorticism due to the increased risk of worsening the patient's condition. You may require a dose adjustment and more frequent clinical monitoring to safely use this medicine. An alternative treatment option may be necessary in some cases based on the clinical condition.

Ocular Toxicities

This medicine should be used with caution due to the increased risk of ocular toxicities such as glaucoma, increased intraocular pressure, etc. This risk is especially higher in patients with a history of ocular disease. Report any unusual symptoms to the doctor immediately. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.
Food interactions
Information not available.
Lab interactions
Information not available.
Apply a thin layer of the cream to the affected areas of the skin as instructed by the doctor. Follow all the usage instructions mentioned on the label or the package insert. Do not apply in larger or smaller quantities than recommended. Do not cover the application area with bandages or other coverings unless specifically instructed by the doctor. Contact your doctor if symptoms do not improve or resolve after two weeks of use.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

Does not cause sleepiness

How it works
This medicine works by reducing the action of certain chemicals that cause swelling and irritation of the skin.
Legal Status

Approved

Approved

Unknown

Unknown

Classification

Category

Topical steroids

Schedule

Schedule H

Halobetasol: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2017 [cited 14 September 2017]. Available from:

https://medlineplus.gov/druginfo/meds/a601060.html

Ulobetasol - DrugBank [Internet]. Drugbank.ca. 2017 [cited 14 September 2017]. Available from:

https://www.drugbank.ca/drugs/DB00596

Halobetasol [Internet]. Pubchem.ncbi.nlm.nih.gov. 2017 [cited 14 September 2017]. Available from:

https://pubchem.ncbi.nlm.nih.gov/compound/5311167#section=Top

[Internet]. Accessdata.fda.gov. 2020 [cited 24 January 2020]. Available from:

https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/019967s015lbl.pdf
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 13 Feb 2020

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.